The Effect of AKST4290 on Choroidal Blood Flow in Patients with Neovascular Age-Related Macular Degeneration
Latest Information Update: 20 Jul 2020
At a glance
- Drugs Lazucirnon (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Acronyms AMD ChBF; STEEL
- Sponsors Alkahest
- 09 Jul 2020 According to an Alkahest media release, biomarker analysis is ongoing in this study.
- 09 Jul 2020 Status changed from recruiting to completed, according to an Alkahest media release.
- 07 Nov 2019 New trial record